GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Net Margin %

Biolife Sciences (Biolife Sciences) Net Margin % : -46.83% (As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Biolife Sciences's Net Income for the three months ended in May. 2008 was $-0.84 Mil. Biolife Sciences's Revenue for the three months ended in May. 2008 was $1.80 Mil. Therefore, Biolife Sciences's net margin for the quarter that ended in May. 2008 was -46.83%.

The historical rank and industry rank for Biolife Sciences's Net Margin % or its related term are showing as below:


BLFE's Net Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -1.34
* Ranked among companies with meaningful Net Margin % only.

Biolife Sciences Net Margin % Historical Data

The historical data trend for Biolife Sciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Net Margin % Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
Net Margin %
- -25,100.00 -4.51 -23.78

Biolife Sciences Quarterly Data
Nov04 Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.18 -16.13 -44.37 -30.16 -46.83

Competitive Comparison of Biolife Sciences's Net Margin %

For the Medical Instruments & Supplies subindustry, Biolife Sciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biolife Sciences's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's Net Margin % falls into.



Biolife Sciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Biolife Sciences's Net Margin for the fiscal year that ended in Nov. 2007 is calculated as

Net Margin=Net Income (A: Nov. 2007 )/Revenue (A: Nov. 2007 )
=-2.046/8.603
=-23.78 %

Biolife Sciences's Net Margin for the quarter that ended in May. 2008 is calculated as

Net Margin=Net Income (Q: May. 2008 )/Revenue (Q: May. 2008 )
=-0.842/1.798
=-46.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biolife Sciences  (OTCPK:BLFE) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Biolife Sciences Net Margin % Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biolife Sciences (Biolife Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired 09-15-2020